Elias Ortega Chahla on IDH-Mutant Glioma and Regional Collaboration
Elias Ortega Chahla/LinkedIn

Elias Ortega Chahla on IDH-Mutant Glioma and Regional Collaboration

Elias Ortega Chahla, Medical Director (Hematology/Oncology), IQVIA, shared a post on LinkedIn:

“I’m truly grateful to Servier for the opportunity to speak at their symposium, ‘Changing the Landscape of IDH-mutant Glioma,’ during the Society of Neuro-Oncology in Latin America meeting in São Paulo, Brazil.

It was a privilege to share the stage with such an inspiring group of experts, including Macarena de la Fuente, and to be part of meaningful conversations focused on improving outcomes for patients with IDH-mutant gliomas.

Experiences like this remind me how powerful collaboration is in advancing neuro-oncology across our region. Thank you again for the invitation and for fostering such an engaging and forward-looking dialogue.”

Elias Ortega Chahla

Other articles featuring Elias Ortega Chahla on OncoDaily.